A new market study, titled “Discover Global Cardiac Biomarkers Market Upcoming Trends, Growth Drivers and Challenges” has been featured on WiseGuyReports.
Cardiac biomarkers are used to diagnose heart-related diseases, that are caused by insufficient blood supply to the heart. These biomarkers are released into the blood if the heart is damaged or stressed. Heart diseases such as acute coronary syndrome (ACS), cardiac ischemia, myocardial infarction is diagnosed with the help of cardiac biomarkers. These biomarkers are also useful to predict heart-related diseases in advance. A biomarker test can help the physician to understand if more invasive procedure is needed to rectify the heart condition.
The global market for cardiac biomarkers is growing due to changes in lifestyles, increasing stress levels, leading to complex heart diseases. Rising geriatric population is also a major reason for the growth of cardiac biomarker market. Physicians are now advising to go for regular checkups to help patients having cardiac risks. Biomarkers help in studying the heart condition efficiently and advance prediction often leads to taking necessary preventive measures. These cardiac biomarkers include enzymes, hormones, and proteins. The level of biomarker in blood helps to understand the heart condition.
Cardiac Biomarkers are helping in diagnosing cardiac cases efficiently. However, the biomarkers activate itself in 2 to 24 hours depending on its type. It is not possible to diagnose in case of acute diseases, where time is the essence. However, several new techniques and compounds are being introduced in the market, which can help the physicians to detect cardiac emergencies more accurately.
The global market for cardiac biomarkers is unique as it deals with the physiology directly. The effect of the components can vary from person to person. It is critical to have a thorough analysis of the market to understand the requirements and development areas. The global market for cardiac biomarkers is segmented based on the cardiac biomarker test, application and testing location. Troponin (I or T), Creatine kinase (CK), Myoglobin, Galectin-3 and Other Biomarker Tests (hs-CRP, BNP (or NT-proBNP) are covered under cardiac biomarker test. Acute Coronary Syndrome, Congestive Heart Failure, Myocardial infarction (MI), Angina, and Others are covered under the application segment. The testing location covers Laboratory testing and point of care testing.
The regional analysis of cardiac biomarkers is equally important. Geographical locations, cultural and ethnic values, lifestyles play an important part in understanding the customer profiles. North American market for cardiac biomarker is growing due to change in lifestyle, that leads to obesity and increasing number of cardiac patients. The European market is also witnessing a similar pattern due to work pressures and changing lifestyle patterns. Increasing consumption of processed foods is also a major contributor to the rise in cardiac cases. Asia Pacific region is a growing market for cardiac biomarkers as rise in geriatric population
is playing an important role. Inclination towards consuming junk and processed food is also a major contributor to rising number of cardiac cases.
Scientists have found during recent studies that high-sensitivity troponin (hs-TnT and N-terminal prohormone BNP (NT-proBNP) helps in identifying patients with high – risk kidney diseases.
Company Name: Wiseguyreports.com
Contact Person: Norah Trent
Email: Send Email
Phone: +1 646 845 9349, +44 208 133 9349